ArticleBMC cancer2016

Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000-2013.

Tumas Beinortas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.